Clinical features and mortality due to human immunodeficiency virus type-1 (HIV-1) infection in women are described as part of a prospective 4-year cohort study on perinatal transmission of HIV in Kigali, Rwanda. Two 
In Africa, although the male-to-female sex ratio is close to 1:l for AIDS cases, estimates of the HIV seroprevalence among young adults frequently give higher figures for women than men. In populationbased HIV serosurveys performed in Uganda in 1989, women had an infection rate 1.4 times higher than that for men (4). Similar observations have been made in Rwanda (5) .
The clinical aspects and the natural history of HIV infection among women have been primarily documented in Europe and in the United States (6-9). In these women, injecting drug use is the major risk factor for acquisition of HIV infection. It is conceivable that such observations cannot be extrapolated to African women who acquire HIV infection most likely by heterosexual intercourse, live in a very different socioeconomical and microbiological environment. and whose clinical management is also much more limited. At the present, few data are available on the specific characteristics of the natural history of HIV infection in African women (10) .
The aim of this study is to describe events occurring over a 4-year prospective clinical follow-up in an already existing cohort of HIV-infected women after delivery in Kigali, Rwanda, in order to ultimately provide recommendations for improving the quality of care in this African environment.
SUBJECTS AND METHODS
In an ongoing prospecure cohort study on mother-to-child transmission of HIV-1, two groups of HIV-seropositive (HIV +) and seronegative (HIV-I women were enrolled at delivery at the maternity ward of the Centre Hospitalier de Kigali (CHK) and followed up. Details of the enrollment and follow-up procedures have been published elsewhere (1 1.12). Briefly, HIV testing was systematically offered between November 1988 and June 1989 to all women delivering in the matemity ward of the CHK and accepting the principles of the study. We enrolled consecutively those women who fulfilled the following inclusion criteria: delivering a live living permanently within the city limits, and giving informed consent to participate. A group of HIV-women of comparable maternal age and parity was consecutively selected as a comparison group. Pretest infomation, objectives. constraints. and benefits of the study were related to each \voman at dciivery by a trained social worker. Posttest counselling was given to those who wanted to know their HIV serostatus or those of their children during the study period.
The women were systemaridly examined at 3-month intervals over the 4 years of follow-up by practitioners who were blinded to the HIV SerostZNs and focused on signs and symptoms of the World Health Ckganization (WHO) clinical case definition for AIDS in adults (13) . A standardized questionnaire was applied during each cons~ntion to collect data on symptoms and hospitalizations occumng during the past trimester. Medical care was provided free of charge in both groups throughout the study period.
At delivery, a blood sample was collected from the mother and HIV -I-women were compared to HIV -women for morbidity and mortality. When a seroconversion occurred in an HIVwoman, she was excluded from the comparison group from the &te of diagnosis of her seroconversion. Clinical outcomes were studied with use of available information collected by standardized follow-up questionnaires and hospital records (16) . Incidence density rates of symptoms (expressed as rates per 100 women-years [WU]), clinical signs, and diseases such as tuberculosis were computed. A research of women lost to follow-up at four years was performed by a radio call in the city. Women who were known alive at that time but could not be examined contributed to the denominator for the survival analysis.
Chi-square test, Fisher's exact test, and Student's I test were used for comparisons, with a significance level of 0.05. Relative risks IRR) were computed to measure the strength of association for incidence density rates with their 95% confidence intervals (CI) according to the semi-exact merhod. For HIV+ women, cumulative probabilities of survival and of remaining AIDS-free were computed according to the KaplakMeier product limit method and their 95% CI by Rothman's formula (17) . Univariate analysis and the descendant stepwise IOgistic regression model were used to study the determinants of mortality in relation to maternal characteristics recorded at the time of delivery. The following variables were studied as potential risk factors: age <25 years, reproductive history with at least one spontaneous abortion, unstable sexual relationship, IOW income. presence of clinical signs and symptoms of HIV infection. and CD4/CD8 ratio <O.S.
RESULTS
Details about the results obtained at enrollment in the study have been given elsewhere (11, 12) . In brief. the two groups of 215 HIV+ and 216 HIVwomen gave 218 live births, respectively. The mean maternal age was 25.1 years (SD: 4.5 years) and the otd number of pregnancies was 2.7 (SD: 1.8 in the HIV-group). . ' ted for 594 WY of clinical follow-up. and women for 637 WY ( Table 1) . Clinical foltaking into account the additional information provided by those women who died (n = 29>, seroconverted (n = 20), or were lost to clinical follow-up before the end of the fourth year (n = 176), 76% of the theoretical clinical follow-up of the cohort was available for the evaluation of the morbidity (Table  1) . There were no si-gnifkant differences in terms of demographic or clinical characteristics at time of inclusion of the women who were clinically followed up over the study period compared with those lost to follow-up (data not shown). After the radio call in the city, 299 women were known to be alive after 4 years, accounting for 690 WY of survival in HIV+ women and 727 WY in HIVwomen ( Table 1) . These figures were used for the evaluation of mortality.
Over the entire follow-up period, there were statistically significant differences between HIV + and HIV-women for the occurrence of each of the clinical signs and symptoms of the clinical A I D S case definition (Table 2) . Weight loss, defined as the loss of 10% or more of the body weight measured at 3-month postpartum, generalized lymphadenopathy, generalized pruritis dermatitis, and persistent cough were the most frequently reported symptoms in the group of HIV+ women after 4 years of follow-up. However, herpes zoster was the sign most strongly associated with HIV infection (22 episodes) for a RR of 7.9 ( Table 2) . Seventeen cases of tuberculosis (seven pulmonary, eight extrapulmonary, and two disseminated), of which 14 were confirmed bacteriologically, were (Fig. 1) .
Although the occurrence of AIDS was rare in these HIV+ women, 26 of them (12.1%) died over the 4-year period versus three among HIVwomen (1.4%). Women known to be alive after 4 years accounted for 87.7% of the theoretical followup for survival analysis ( Table 1 (Fig. 2) . The causes of death among HIV+ women were identified in 24 out of the 26 cases (92%): tuberculosis (81, persistent diarrhea (6), pneumonia (3), sep-4). Nine of these variables were introduced in the multivariate logistic regression model. The only parameter significantly associated with 4-year mortality in HIV + women was the presence of persistent cough (p = 0.048; odds ratio, 2.66; CI, 1.01-7.01).
DISCUSSION
Although women are estimated to represent more than half of the population of HIV-infected people worldwide (2) , very few data are available on the natural history of HIV infection in women. The present study is an attempt to partially fdl this gap in an African setting, providing long-term follow-up information. Our evaluation of the natural history of HIV infection had to suffer, however, a major constraint because of its prevalent cohort design (18) . Indeed, the ideal way to describe the natural history of HIV infection is to follow incident cohorts. Such groups are difficult to identify and enroll, particularly in Africa. The main objective of our cohort study was the evaluation of the mother-to-child transmission rate of HIV. The women participating in our study, however, had just completed a pregnancy, were mostly asymptomatic at enrollment, but had an unknown duration of HIV infection. Our clinical observations collected prospectively in a systematic fashion with a comparison group of HIV-women may be used to approximate the "true" natural history of HIV infection in this population. The follow-up rafe was high enough and comparable between the two groups to guarantee that unbiased conclusions were drawn from this analysis (16) .
In our study, the cumulative probability of reach- ing the AIDS stage is 4.5% after 2 years of follow-up and 13.5% after 4 years in HIV-t-women. These figures are consistent with those described by Lindan and co-workers in another prevalent cohort of Rwandan women followed for 2 years (10). In addition. when comparing our study with those performed in other population groups in industrialized countries, our figure falls within the range of values already obtained, the cumulative probability of developing AIDS varying between 17.5% after 4 years among European women (7) and 21% among women after an index delivery (9) . Although these studies used various definitions of AIDS and were also prevalent studies, this comparison suggests that the course of the HIV infection is not dramatically different in populations of women from industrialized countries compared with those from Africa.
NATURAL HISTOR Y OF HIV-1 INFECTION I N AFRICAN WOMEN
After four years of follow-up, the mortality rate among HIV + women was nine times higher than in HIV -women. These figures are lower than those obtained in a Ugandan rural adult population where the annual mortality rate was 11.6% (19, 20) . This difference may be explained by the lack of medical care in this rural population in contrast to our cohort or by the prevalent design. More than half of the deaths among the HIV-infected group occurred in women not fulfilling the clinical definition of AIDS in our study. This suggests that the lifethreatening manifestations of HIV infection in African women are much broader than those strictly included in the AIDS case definition, as suggested earlier (10, 20) . Thus, the clinical definition of A I D S proposed in Bangui in 1986 may be seen as a tool of limited value for the evaluation of HIV-related mortality (13, 21) .
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Ure is consistent with those found in other cohort studies in Africa (22, 23) . At any stage of HIV infection, subjects are at increased risk of reactivating a latent M. tuberculosis infection and probably also to acquire primary infection (24, 25) . Thus, the HIV epidemic has a striking effect, particularly in Africa, on the magnitude of the tuberculosis burden (26, 27) . It is noteworthy that in our multivariate analysis of risk factors of death in HIV + women, the only clinical sign predictive of death is chronic cough at enrollment. This suggests that chronic cough should be considered as an early marker of a pejorative evolution of HIV infection in relation to tuberculosis or other pulmonary complications. The fact that profound immunosuppression was not predictive of mortality does not imply that this epidemiological association does not exist.
plications of HIV infection such as pneumococcal infection are readily treatable by appropriate chemotherapy, making early clinical management of HIV-infected individuals feasible even in the developing world (28). In addition, in africa, the evaluation of pragmatic approaches designed to prevent or treat early tuberculosis in HIV-infected patients should be considered of utmost priority. In the con- 
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childbearing age should be targeted as they already pay a heavy tribute to the HIV pandemic.
